Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

NCT04711486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment Due to Alzheimer's Disease

Interventions

DRUG: Contraloid acetate
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]